FDA has indicated Moxidectin from Medicines Development for Global Health to treat onchocerciasis (river blindness) resulting from Onchocerca volvulus in patients aged 12 years and older. The drug won that indication in June 2020. The drug is the first novel treatment for river blindness in two decades. The anthelmintic drug also has veterinary applications. It is…
The most innovative pharmaceutical agents of 2020
The Galien Foundation recently announced nominees for most innovative pharmaceutical agents for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical, pharmaceutical drugs and medical technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien…